165 related articles for article (PubMed ID: 21807464)
21. Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer.
Glockzin G; Ghali N; Lang SA; Schlitt HJ; Piso P
J Surg Oncol; 2009 Sep; 100(4):306-10. PubMed ID: 19697436
[TBL] [Abstract][Full Text] [Related]
22. Cytoreductive surgery (cs) and hyperthermic intraperitoneal chemotherapy (hipec) in treatment of peritoneal surface malignances: report of a phase II clinical study.
Asero S; Caruso M; Vallone N; Luciani AG; Lombardo V; Terranova G; Ettore G; Giannone G
In Vivo; 2009; 23(4):645-7. PubMed ID: 19567402
[TBL] [Abstract][Full Text] [Related]
23. The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus.
Baratti D; Kusamura S; Deraco M
J Surg Oncol; 2008 Sep; 98(4):258-62. PubMed ID: 18726888
[TBL] [Abstract][Full Text] [Related]
24. Laparoscopic hyperthermic intraperitoneal chemotherapy for the management of advanced peritoneal carcinomatosis.
Halkia EA; Kyriazanos J; Efstathiou E; Spiliotis JD
Hepatogastroenterology; 2011; 58(112):1915-7. PubMed ID: 22234061
[TBL] [Abstract][Full Text] [Related]
25. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts.
Elias D; Detroz B; Debaene B; Damia E; Leclercq B; Rougier P; Lasser P
Hepatogastroenterology; 1994 Jun; 41(3):207-13. PubMed ID: 7959539
[TBL] [Abstract][Full Text] [Related]
26. Hyperthermia and intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis: an experimental study.
Klaver YL; Hendriks T; Lomme RM; Rutten HJ; Bleichrodt RP; de Hingh IH
Ann Surg; 2011 Jul; 254(1):125-30. PubMed ID: 21502859
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
[TBL] [Abstract][Full Text] [Related]
28. Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy.
van Ruth S; Verwaal VJ; Hart AA; van Slooten GW; Zoetmulder FA
Anticancer Res; 2003; 23(2B):1501-8. PubMed ID: 12820416
[TBL] [Abstract][Full Text] [Related]
29. Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: state of the art and future developments.
Roviello F; Caruso S; Marrelli D; Pedrazzani C; Neri A; De Stefano A; Pinto E
Surg Oncol; 2011 Mar; 20(1):e38-54. PubMed ID: 20888755
[TBL] [Abstract][Full Text] [Related]
30. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CS) as treatment of peritoneal carcinomatosis: preliminary results in Croatia.
Majerović M; Milinović D; Oresković S; Matosević P; Mirić M; Kekez T; Kinda E; Augustin G; Silovski H
Coll Antropol; 2011 Dec; 35(4):1349-52. PubMed ID: 22397286
[TBL] [Abstract][Full Text] [Related]
31. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
Witkamp AJ; de Bree E; Van Goethem R; Zoetmulder FA
Cancer Treat Rev; 2001 Dec; 27(6):365-74. PubMed ID: 11908929
[TBL] [Abstract][Full Text] [Related]
32. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
33. Peritoneal carcinomatosis: intra-operative and post-operative assessment of patients undergoing cytoreduction and HIPEC.
Spiliotis J; Vaxevanidou A; Datsis A; Rogdakis A; Kekelos S
Hepatogastroenterology; 2010; 57(102-103):1052-9. PubMed ID: 21410030
[TBL] [Abstract][Full Text] [Related]
34. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
35. The randomized trial of cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion: what it does and does not tell us.
Levine EA
Ann Surg Oncol; 2008 Oct; 15(10):2633-5. PubMed ID: 18696161
[No Abstract] [Full Text] [Related]
36. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.
Yan TD; Deraco M; Baratti D; Kusamura S; Elias D; Glehen O; Gilly FN; Levine EA; Shen P; Mohamed F; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH
J Clin Oncol; 2009 Dec; 27(36):6237-42. PubMed ID: 19917862
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and pharmacodynamics of cisplatin after intraoperative hyperthermic intraperitoneal chemoperfusion (HIPEC).
Zeamari S; Floot B; van der Vange N; Stewart FA
Anticancer Res; 2003; 23(2B):1643-8. PubMed ID: 12820435
[TBL] [Abstract][Full Text] [Related]
38. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
[TBL] [Abstract][Full Text] [Related]
39. The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.
Aarts F; Bleichrodt RP; de Man B; Lomme R; Boerman OC; Hendriks T
Ann Surg Oncol; 2008 Nov; 15(11):3299-307. PubMed ID: 18712445
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program.
Chua TC; Martin S; Saxena A; Liauw W; Yan TD; Zhao J; Lok I; Morris DL
Ann Surg; 2010 Feb; 251(2):323-9. PubMed ID: 20040853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
